The International Institute of Molecular and Cell Biology in Warsaw undertakes to ensure the availability of its website in accordance with the provisions of the Act of April 4, 2019 on digital accessibility of websites and mobile applications of public entities. The accessibility statement applies to the website of the International Institute of Molecular and Cell Biology in Warsaw.
Website publication date: October 27, 2017
Date of the last significant update: September 30, 2022
The website is partially compliant with the Digital Accessibility Act of Public Entity's Websites and Mobile Applications due to incompatibilities or exemptions listed below.
The website is partially compliant with the Act of April 4, 2019 on digital accessibility of websites and mobile applications of public entities. There may be situations where, despite the efforts of the portal editors, some content and documents published on the website are digitally unavailable due to, among others:
were published before the entry into force of the Digital Accessibility Act
are sharing / borrowing from other sites
are published as .pdf files, which are scans of documents
On the website, there are also cases of graphics without alternative text.
the videos posted on the website may not have subtitles or a voice-over, as their publication took place before the entry into force of the Digital Accessibility Act or come from third party sources.
documents and content developed and published before 23/09/2018, and documents or presentations are archival in nature, and their content does not condition the implementation of the current tasks of the Institute
The declaration was made on: 30/03/2021
The declaration was last reviewed and updated on: 30/03/2021
The declaration is based on a self-assessment.
Responsible for considering comments and motions: Daria Goś.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Telephone: 22 5115 562
Everyone has the right:
make comments on the digital accessibility of the webpage or its element,
make a request to ensure the digital availability of a webpage or its element,
make a request that unavailable information be made available in another alternative form.
The request must include:
contact details of the reporting person,
indication of the webpage or element of the webpage to which the request relates,
indication of a convenient form of disclosing information, if the request concerns disclosure of unavailable information in an alternative form.
Consideration of the notification should take place immediately, at the latest within 7 days. If it is not possible to meet this deadline, the public entity shall immediately inform about when it will be possible to fulfill the request, and the deadline may not be longer than 2 months. If availability cannot be ensured, the entity may propose an alternative way of accessing the information.
Failure to meet these deadlines and the refusal to fulfill the request or alternative access to information, you can submit a complaint to the supervisory body by post or by e-mail to the following address:
Supervisory body: International Institute of Molecular and Cell Biology in Warsaw
Address: International Institute of Molecular and Cell Biology in Warsaw, 4 Ks. Trojdena Street, 02-109 Warsaw, Poland
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Telephone: 22 597 07 00
After exhausting all possibilities, the complaint may also be sent to the Commissioner for Human Rights (Rzecznik Praw Obywatelskich).
The International Institute of Molecular and Cell Biology in Warsaw is located in buildings at 4 Ks. Trojdena Street and 2 Hankiewicza Street, both in Warsaw, Poland. Buildings are not adapted to the needs of people with disabilities.
The Institute provides people with special needs contact by phone, correspondence, and audiovisual communication (using instant messengers). Access to the building is possible for people using an assistance dog.
No special keyboard shortcuts have been used on the Institute's website. The Institute does not own and does not provide any mobile applications. Work is underway to convert the content on the website to make it available in the most possible digitally and meet the requirements of WCAG 2.1. at the AA level.
IIMCB INTERNSHIP PROGRAM FOR STUDENTS
The International Institute of Molecular and Cell Biology in Warsaw (IIMCB) is an internationally recognized research institute focusing on RNA and cell biology. In line with the IIMCB’s mission we support ambitious scientists at all stages of career and of any nationality to pursue scientific discoveries to respond to health-related societal challenges and report them in high-quality publications.
The IIMCB hosts a vibrant, multinational community of scientists and is well connected internationally, as evidenced by the composition of the IIMCB’s International Advisory Board and the IIMCB’s membership in the EU-LIFE, an alliance of 15 top European independent research institutes. The IIMCB has an excellent record in attracting national and international funding and a high proportion of EMBO members and ERC laureates among its group leaders.
We are looking for talented, dynamic and highly motivated pre-doctoral students with background in life sciences especially biology. You will work on research projects in IIMCB laboratories under the supervision of excellent scientists. You will have the opportunity to work in highly international teams on challenging questions of modern science as well as improve your scientific and analytical skills.
If you are interested in working with us, we encourage you to view the research topics of each laboratory and apply for this internship program.
How to apply:
The Internship Program accepts applications on a rolling basis. Students enrolled in a Bachelor or Master program or those who recently obtained such degree are eligible.
The number of internships is limited. Only the candidates selected in the recruitment procedure will be offered an internship.
One of the priorities of IIMCB is to foster a working environment in which all individuals are treated equally, with respect and with fairness. Accordingly, the Director of IIMCB established a Working Group on Gender Equality Opportunities, which included representatives of researchers at all career levels and representatives of the administration. The responsibilities of the group shall include, in particular, the preparation of a gender equality plan for IIMCB, coordination of the implementation of activities in the area of gender equality and advice on geneder equality issues.
We present to you the Gender Equality Plan for the International Institute of Molecular and Cell Biology in Warsaw (hereafter referred to as IIMCB or the Institute) for the period 2022-2025 (hereafter referred to as the "Gender Equality Plan"). The Gender Equality Plan was prepared for the entire IIMCB community - persons employed on the basis of an employment contract, PhD students, MSc students and volunteers associated with IIMCB:
Horizon for Excellence in messenger RNA applications in immunoOncology (HERO)
mRNA technology is the future of biological drugs. It is currently one of the most innovative directions of development in the medical and pharmaceutical industry. This is also the topic of research of the HERO project, funded by the Polish Science Fund within the Virtual Research Institute. In the HERO project, an interdisciplinary team of scientists uses their experience and original ideas to develop a therapeutic mRNA technology that can be used in cancer immunotherapy. In addition, the project also aims to refine the mRNA technology and apply it to the treatment of other diseases.
Project is implemented in consortium of four scientific institutions: the leader - International Institute of Molecular and Cell Biology in Warsaw (IIMCB), Institute of Physical Chemistry of the Polish Academy of Sciences (IPC), University of Warsaw (UW), Medical University of Warsaw (MUW).
Interdisciplinary research team:
Leader:
Key members:
Contact:
Project is financed within the Virtual Research Institute of the Polish Science Fund source.
Virtual Research Institute (VIB) is a program financing research with a high commercialization potential in one of the key areas for society i.e. medical biotechnology – oncology. The Virtual Research Institute was defined by The April 4, 2019 Act on Supporting Scientific Activity From the Polish Science Fund. VIB is dedicated to the most talented polish scientists conducting research activities on the highest world class level – representants of universities as well as of scientific and research institutes. The Minister of Science and Higher Education allocated PLN 450 million for goal of VIB. The objective of the Research Team is to develop a new technology or group of technologies in accordance with specific procedures and standards necessary for its commercialization and implementation within a maximum of five years from commencing the work.
The mission of the Microscopy and Cytometry Facility (MCF) is to provide expertise and support in experimental work involving advanced microscopy of biological specimens, and cell sorting. The current services that are provided by the facility can be divided into three groups.
The cell sorting service is provided using a Becton Dickinson FACSAria II and Beckman Coulter CytoFLEX SRT cell sorters. FACSAria II is equipped with three lasers (violet, blue, and red) and nine fluorescence detectors. CytoFLEX SRT is equipped with four lasers (violet, blue, yellow-green and red) and fifteen fluorescence detectors. Up to four populations can be sorted simultaneously. Cell sorting is offered as a full service for occasional customers and users and as equipment access for researchers who are experienced in flow cytometry.
The facility provides access to a broad range of fluorescence light microscopes. Most of our microscopes allow optical sectioning, such as confocal (point-scanning or spinning-disk), two-photon, lightsheet, and total internal reflection fluorescence (TIRF), to facilitate high-contrast fluorescence imaging. The facility’s newest acquisition is Opera Phenix, a high-content screening system from PerkinElmer for the large-scale imaging of cells (e.g., in RNAi-based microscopy screens) in widefield or confocal mode. Our equipment also includes a Zeiss LSM800 confocal microscope with a high-resolution Airyscan detector, a Zeiss LSM710 NLO dual confocal/multiphoton microscope for the live imaging of cells and tissues, an Andor Revolutions XD system for real-time spinning-disk confocal microscopy and TIRF imaging, a Zeiss Lightsheet Z.1 single-plane illumination microscope for the imaging of fluorescently labeled zebrafish larvae, an Olympus CellR/ScanR imaging station for intracellular calcium measurements, and a Nikon 80i Eclipse microscope with a scanning stage for the mosaic imaging of histochemically or fluorescently stained tissue sections. Two- and three-dimensional image analysis is possible using dedicated software, such as Imaris (Bitplane) and Harmony (PerkinElmer). Full imaging services are also possible on the most sophisticated microscopy platforms.
The electron microscopy service offers analyses of cells, tissues, and virus particles with a FEI Tecnai T12 transmission electron microscope. For the conventional transmission electron microscopy of cells and tissue samples, we use a Leica EM tissue processor. This enables resin processing under constant temperature while avoiding exposure to toxic substances. After saturation with resin, tissue and cell specimens are pre-trimmed with a Leica EM TRIM2, which prepares for the next step of processing. Samples are then cut for semi- and ultra-thin sections using a Leica EM UC7 ultramicrotome, and then sections are placed on electron microscopy grids. Material that is prepared this way can be imaged with our electron microscope.
The MCF operates in either full-service mode or access mode, depending on equipment, application, and the customer. In the latter mode, our staff offers initial training for users and assistance with experimental design, data analysis, and final data interpretation. The MCF is open to IIMCB researchers and external customers from academia and industry.
The detailed list of equipment with description and contact names is available under the “Equipment“ tab in the “Core Facilities” menu.
IN-MOL-CELL Infrastructure:
Cutting-Edge Support for R&D
